Pharmacists should be “cautious” when using pregabalin capsules labelled with the incorrect strength, the Medicines and Healthcare products Regulatory Authority (MHRA) has warned.

The “majority of cartons” from one batch of the epilepsy drug are likely to contain "one or two" blisters labelled as both 25mg and 75mg, the medicines watchdog said yesterday (August 12).

Teva notified the MHRA about the printing error, which means that affected blister packs have the incorrect strength of 25mg printed in one position. The correct strength is still printed on other parts of the packs as well as on their carton labels and information leaflet, the MHRA stressed.

The stock has not been recalled “to ensure continuity of supply”, it said. “However, no further stock with this error will be released to the market,” the MHRA added.

General enquiries about the error should be directed to Teva UK’s customer service team on 0800 590502. Medical queries should be directed to Teva UK on 0207 5407117 or [email protected].

Affected batch:

Do you have any packs from the affected batch?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information